General Information of Drug (ID: DM5GMOJ)

Drug Name
NEORAUTENOL Drug Info
Synonyms Neorautenol; CHEMBL1098728; BDBM50317432
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Cross-matching ID
PubChem CID
11500744
TTD Drug ID
DM5GMOJ

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Approved Drug(s)
Clinical Trial Drug(s)
Discontinued Drug(s)
Investigative Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Oseltamivir DMGO72P Influenza 1E30-1E32 Approved [3]
Zanamivir DMFMBZ4 Influenza 1E30-1E32 Approved [3]
Peramivir DMNXY5K Influenza virus infection 1E30-1E32 Approved [4]
UX-001 DMD2O0L Hereditary inclusion body myositis 4A41.2 Phase 3 [5]
CS-8958 DM4CSDH Influenza virus infection 1E30-1E32 Phase 3 [4]
DAS-181 DM0Y8JP Influenza virus infection 1E30-1E32 Phase 2 [6]
Lactose DMO4GPK Discovery agent N.A. Phase 1 [5]
GS-3435 DMV7JC6 Influenza virus infection 1E30-1E32 Terminated [7]
BCX-140 DMBJERO Influenza virus infection 1E30-1E32 Terminated [8]
Alpha-D-Mannose DMF5DLW Discovery agent N.A. Investigative [5]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [9]
TRYPAN BLUE DM4NTMO Ophthalmic surgery injury PK97 Approved [10]
URSOLIC ACID DM4SOAW Metabolic syndrome x 5C50-5D2Z Phase 2 [1]
ISIS 113715 DMUPD4G Type-2 diabetes 5A11 Phase 2 [11]
ISIS-PTP1Brx DMJGVXT Type-2 diabetes 5A11 Phase 2 [12]
ERTIPROTAFIB DMJXEV7 Type-2 diabetes 5A11 Terminated [13]
Acetate Ion DMD08RH Discovery agent N.A. Investigative [5]
B-Octylglucoside DMMO75G Discovery agent N.A. Investigative [5]
2-Methyl-2,4-Pentanediol DMD45CU Discovery agent N.A. Investigative [5]
Double Oxidized Cysteine DM6TU84 Discovery agent N.A. Investigative [5]
⏷ Show the Full List of 10 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Influenza Neuraminidase (Influ NA) TT50QJ3 NRAM_I33A0 Inhibitor [2]
PTPN1 messenger RNA (PTPN1 mRNA) TTELIN2 PTN1_HUMAN Inhibitor [1]

References

1 Cytotoxic and PTP1B inhibitory activities from Erythrina abyssinica. Bioorg Med Chem Lett. 2009 Dec 1;19(23):6745-9.
2 Prenylated pterocarpans as bacterial neuraminidase inhibitors. Bioorg Med Chem. 2010 May 1;18(9):3335-44.
3 Current and future antiviral therapy of severe seasonal and avian influenza. Antiviral Res. 2008 Apr;78(1):91-102.
4 Developing new antiviral agents for influenza treatment: what does the future hold Clin Infect Dis. 2009 Jan 1;48 Suppl 1:S3-13.
5 How many drug targets are there Nat Rev Drug Discov. 2006 Dec;5(12):993-6.
6 Inhibition of neuraminidase inhibitor-resistant influenza virus by DAS181, a novel sialidase fusion protein. PLoS One. 2009 Nov 6;4(11):e7838.
7 US patent application no. 2010,0081,713, Compositions and methods for treating viral infections.
8 CN patent application no. 104447481, Benzoic acid thiourea anti-influenza virus compounds as well as preparation method and use thereof.
9 Periodinates: a new class of protein tyrosine phosphatase inhibitors. Bioorg Med Chem Lett. 1999 Feb 8;9(3):353-6.
10 Evans Blue and other dyes as protein tyrosine phosphatase inhibitors. Bioorg Med Chem Lett. 2004 Apr 19;14(8):1923-6.
11 Clinical pipeline report, company report or official report of ISIS Pharmaceuticals (2009).
12 Clinical pipeline report, company report or official report of ISIS Pharmaceuticals.
13 2-O-carboxymethylpyrogallol derivatives as PTP1B inhibitors with antihyperglycemic activity. Bioorg Med Chem Lett. 2007 Oct 1;17(19):5357-60.